Duchenne Therapy, Fibromyalgia Genetics, Biotech Deals
Kilder
- GEN: Landmark Phase III Trial Finds Cell Therapy Slows Muscle Decline in Advanced DMD
- Newswise: The Lancet Publishes Landmark Trial of Duchenne Muscular Dystrophy Therapy | Newswise - Newswise
- GEN: Base Editing Strategy Alleviates Huntington’s Disease in Mice - genengnews.com
- BioPharma Dive: Caldera, Vidya add to recent flurry of biotech mergers
- BioPharma Dive: MapLight CEO on what investors missed in the biotech’s schizophrenia data - BioPharma Dive
- STAT: STAT+: Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicated
- STAT: Clinical chatbots are taking medicine by storm. Should doctors trust them? - STAT
- STAT: NSF testing new Ph.D. model giving trainees academic and industry experience - STAT
- GEN: Genetic Study of Fibromyalgia Points to Neurological Basis
- Technologynetworks: Largest-Ever Genetic Study of Fibromyalgia Points to a Neurological Origin - Technology Networks
- GEN: Base Editing Strategy Alleviates Huntington’s Disease in Mice - genengnews.com
- GEN: Base Editing Strategy Alleviates Huntington’s Disease in Mice
- News-medical: New gene editing tool reduces Huntington's symptoms in mice - News-Medical
- GEN: Genetic Study of Fibromyalgia Points to Neurological Basis - genengnews.com
- BioPharma Dive: MapLight CEO on what investors missed in the biotech’s schizophrenia data
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.